COVID-19 Impact on Global Oncology Biomarker Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Oncology Biomarker Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Oncology Biomarker Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Lung Cancer
  • 1.4.3 Breast Cancer
  • 1.4.4 Colorectal Cancer
  • 1.4.5 Prostate Cancer
  • 1.4.6 Stomach Cancer
  • 1.4.7 Others
• 1.5 Market by Application
  • 1.5.1 Global Oncology Biomarker Market Share by Application: 2020 VS 2026
  • 1.5.2 Diagnostics
  • 1.5.3 Drug Discovery And Development
  • 1.5.4 Prognostics
  • 1.5.5 Risk Assessment
  • 1.5.6 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Oncology Biomarker Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Oncology Biomarker Industry
    • 1.6.1.1 Oncology Biomarker Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Oncology Biomarker Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Oncology Biomarker Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Oncology Biomarker Market Perspective (2015-2026)
• 2.2 Oncology Biomarker Growth Trends by Regions
  • 2.2.1 Oncology Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Oncology Biomarker Historic Market Share by Regions (2015-2020)
  • 2.2.3 Oncology Biomarker Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Oncology Biomarker Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Oncology Biomarker Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Oncology Biomarker Players by Market Size
  • 3.1.1 Global Top Oncology Biomarker Players by Revenue (2015-2020)
  • 3.1.2 Global Oncology Biomarker Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Oncology Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Oncology Biomarker Market Concentration Ratio
  • 3.2.1 Global Oncology Biomarker Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Oncology Biomarker Revenue in 2019
• 3.3 Oncology Biomarker Key Players Head office and Area Served
• 3.4 Key Players Oncology Biomarker Product Solution and Service
• 3.5 Date of Enter into Oncology Biomarker Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Oncology Biomarker Historic Market Size by Type (2015-2020)
• 4.2 Global Oncology Biomarker Forecasted Market Size by Type (2021-2026)

5 Oncology Biomarker Breakdown Data by Application (2015-2026)

• 5.1 Global Oncology Biomarker Market Size by Application (2015-2020)
• 5.2 Global Oncology Biomarker Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Oncology Biomarker Market Size (2015-2020)
• 6.2 Oncology Biomarker Key Players in North America (2019-2020)
• 6.3 North America Oncology Biomarker Market Size by Type (2015-2020)
• 6.4 North America Oncology Biomarker Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Oncology Biomarker Market Size (2015-2020)
• 7.2 Oncology Biomarker Key Players in Europe (2019-2020)
• 7.3 Europe Oncology Biomarker Market Size by Type (2015-2020)
• 7.4 Europe Oncology Biomarker Market Size by Application (2015-2020)

8 China

• 8.1 China Oncology Biomarker Market Size (2015-2020)
• 8.2 Oncology Biomarker Key Players in China (2019-2020)
• 8.3 China Oncology Biomarker Market Size by Type (2015-2020)
• 8.4 China Oncology Biomarker Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Oncology Biomarker Market Size (2015-2020)
• 9.2 Oncology Biomarker Key Players in Japan (2019-2020)
• 9.3 Japan Oncology Biomarker Market Size by Type (2015-2020)
• 9.4 Japan Oncology Biomarker Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Oncology Biomarker Market Size (2015-2020)
• 10.2 Oncology Biomarker Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Oncology Biomarker Market Size by Type (2015-2020)
• 10.4 Southeast Asia Oncology Biomarker Market Size by Application (2015-2020)

11 India

• 11.1 India Oncology Biomarker Market Size (2015-2020)
• 11.2 Oncology Biomarker Key Players in India (2019-2020)
• 11.3 India Oncology Biomarker Market Size by Type (2015-2020)
• 11.4 India Oncology Biomarker Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Oncology Biomarker Market Size (2015-2020)
• 12.2 Oncology Biomarker Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Oncology Biomarker Market Size by Type (2015-2020)
• 12.4 Central & South America Oncology Biomarker Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott Laboratories
  • 13.1.1 Abbott Laboratories Company Details
  • 13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  • 13.1.3 Abbott Laboratories Oncology Biomarker Introduction
  • 13.1.4 Abbott Laboratories Revenue in Oncology Biomarker Business (2015-2020))
  • 13.1.5 Abbott Laboratories Recent Development
• 13.2 Bristol-Myers Squibb
  • 13.2.1 Bristol-Myers Squibb Company Details
  • 13.2.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  • 13.2.3 Bristol-Myers Squibb Oncology Biomarker Introduction
  • 13.2.4 Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2015-2020)
  • 13.2.5 Bristol-Myers Squibb Recent Development
• 13.3 Eli Lilly and Company
  • 13.3.1 Eli Lilly and Company Company Details
  • 13.3.2 Eli Lilly and Company Business Overview and Its Total Revenue
  • 13.3.3 Eli Lilly and Company Oncology Biomarker Introduction
  • 13.3.4 Eli Lilly and Company Revenue in Oncology Biomarker Business (2015-2020)
  • 13.3.5 Eli Lilly and Company Recent Development
• 13.4 F.Hoffmann-La Roche Ltd.
  • 13.4.1 F.Hoffmann-La Roche Ltd. Company Details
  • 13.4.2 F.Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
  • 13.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Introduction
  • 13.4.4 F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2015-2020)
  • 13.4.5 F.Hoffmann-La Roche Ltd. Recent Development
• 13.5 Genomic Health
  • 13.5.1 Genomic Health Company Details
  • 13.5.2 Genomic Health Business Overview and Its Total Revenue
  • 13.5.3 Genomic Health Oncology Biomarker Introduction
  • 13.5.4 Genomic Health Revenue in Oncology Biomarker Business (2015-2020)
  • 13.5.5 Genomic Health Recent Development
• 13.6 GlaxoSmithKline plc
  • 13.6.1 GlaxoSmithKline plc Company Details
  • 13.6.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
  • 13.6.3 GlaxoSmithKline plc Oncology Biomarker Introduction
  • 13.6.4 GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2015-2020)
  • 13.6.5 GlaxoSmithKline plc Recent Development
• 13.7 Novartis AG
  • 13.7.1 Novartis AG Company Details
  • 13.7.2 Novartis AG Business Overview and Its Total Revenue
  • 13.7.3 Novartis AG Oncology Biomarker Introduction
  • 13.7.4 Novartis AG Revenue in Oncology Biomarker Business (2015-2020)
  • 13.7.5 Novartis AG Recent Development
• 13.8 Merck & Co.
  • 13.8.1 Merck & Co. Company Details
  • 13.8.2 Merck & Co. Business Overview and Its Total Revenue
  • 13.8.3 Merck & Co. Oncology Biomarker Introduction
  • 13.8.4 Merck & Co. Revenue in Oncology Biomarker Business (2015-2020)
  • 13.8.5 Merck & Co. Recent Development
• 13.9 Pfizer
  • 13.9.1 Pfizer Company Details
  • 13.9.2 Pfizer Business Overview and Its Total Revenue
  • 13.9.3 Pfizer Oncology Biomarker Introduction
  • 13.9.4 Pfizer Revenue in Oncology Biomarker Business (2015-2020)
  • 13.9.5 Pfizer Recent Development
• 13.10 Qiagen N.V.
  • 13.10.1 Qiagen N.V. Company Details
  • 13.10.2 Qiagen N.V. Business Overview and Its Total Revenue
  • 13.10.3 Qiagen N.V. Oncology Biomarker Introduction
  • 13.10.4 Qiagen N.V. Revenue in Oncology Biomarker Business (2015-2020)
  • 13.10.5 Qiagen N.V. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer